Skip to main content
. 2017 Nov 3;31(6):1103–1114. doi: 10.21873/invivo.11176

Figure 1. Fisetin reduced HSC3 cell viability. HSC3 cells were treated with 0, 20, 40, 60, 80 and 100 μM of fisetin for 24 (A) and 48 (B) h and then cells were collected to determine the total percentage of viable cells by flow cytometry as described in the Materials and Methods section. ***Significant differences at p<0.001 between fisetin-treated groups and the control as analyzed by Dunnett test.

Figure 1